Skip to content

Aquestive Therapeutics, Inc. AQST Property, plant and equipment at cost

Property, plant and equipment at cost at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
Viatris logo
ViatrisVTRS
AbbVie logo
AbbVieABBV
Precigen logo
PrecigenPGEN
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL

Other financials

Income statement

See full
Revenue$14.4M+65.7%
Gross profit$11.0M+117%
Operating income-$4.2M+78.3%
Net income-$8.1M+64.9%
EPS (diluted)-$0.07+70.8%

Balance sheet

See full
Cash & equivalents$110.7M+61.3%
Total debt$64.4M+7.4%
Total equity-$34.1M+44.1%
Total assets$141.1M+38.0%

Cash flow

See full
Operating cash flow-$14.8M+36.7%
CapEx$52.0K-61.5%
Free cash flow-$14.9M+36.9%

Valuation

See full
Market cap$560.13M+73.5%
Enterprise value$513.76M+63.6%
P/S11.1×+5.2×

Profitability

See full
Gross margin63.5%-4.9pp
Operating margin-111.2%+96.3pp
Net margin-137.1%+80.7pp
FCF margin-88.2%-2.2pp

Returns & leverage

See full
Return on equity145.1%
Debt / equity-1.9×
Current ratio4.1×-0.8×

Where this comes from

Reported directly by Aquestive Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aquestive Therapeutics, Inc.'s property, plant and equipment at cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aquestive Therapeutics, Inc.'s property, plant and equipment at cost?
Aquestive Therapeutics, Inc. (AQST) reported property, plant and equipment at cost of $47.97M in Q1 2026.
How has Aquestive Therapeutics, Inc.'s property, plant and equipment at cost changed year-over-year?
Aquestive Therapeutics, Inc.'s property, plant and equipment at cost increased by 1.1% year-over-year, from $47.44M to $47.97M.
What is the long-term trend for Aquestive Therapeutics, Inc.'s property, plant and equipment at cost?
Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s property, plant and equipment at cost has grown at a 0.1% compound annual growth rate (CAGR), from $47.75M to $47.91M.